99 related articles for article (PubMed ID: 23452506)
21. Volume increases in putamen associated with positive symptom reduction in previously drug-naive schizophrenia after 6 weeks antipsychotic treatment.
Li M; Chen Z; Deng W; He Z; Wang Q; Jiang L; Ma X; Wang Y; Chua SE; Cheung C; McAlonan GM; Sham PC; Collier DA; Gong Q; Li T
Psychol Med; 2012 Jul; 42(7):1475-83. PubMed ID: 22030695
[TBL] [Abstract][Full Text] [Related]
22. Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tablets.
Patrick DL; Burns T; Morosini P; Gagnon DD; Rothman M; Adriaenssen I
Clin Ther; 2010 Feb; 32(2):275-92. PubMed ID: 20206786
[TBL] [Abstract][Full Text] [Related]
23. Cognitive-behavioural therapy for patients with schizophrenia: a multicentre randomized controlled trial in Beijing, China.
Li ZJ; Guo ZH; Wang N; Xu ZY; Qu Y; Wang XQ; Sun J; Yan LQ; Ng RM; Turkington D; Kingdon D
Psychol Med; 2015 Jul; 45(9):1893-905. PubMed ID: 25532460
[TBL] [Abstract][Full Text] [Related]
24. Cognitive behaviour therapy in patients with schizophrenia who are not prescribed antipsychotic medication: a case series.
Christodoulides T; Dudley R; Brown S; Turkington D; Beck AT
Psychol Psychother; 2008 Jun; 81(Pt 2):199-207. PubMed ID: 18230197
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
Citrome L; Meng X; Hochfeld M; Stahl SM
Hum Psychopharmacol; 2012 Jan; 27(1):24-32. PubMed ID: 22161738
[TBL] [Abstract][Full Text] [Related]
26. [RÉALITÉ LT, a pharmacoepidemiological study of semiology and therapeutic strategy of patients with schizophrenia treated by antipsychotic loxapine in routine clinical practice].
Cousin FR; Samuelian JC; Saoud M; Schmitt L; Vacheron MN; Vidailhet P; Augendre J; Walter M; Tonelli I; Pascal JC
Encephale; 2012 Feb; 38(1):64-74. PubMed ID: 22381726
[TBL] [Abstract][Full Text] [Related]
27. Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia.
Grant PM; Huh GA; Perivoliotis D; Stolar NM; Beck AT
Arch Gen Psychiatry; 2012 Feb; 69(2):121-7. PubMed ID: 21969420
[TBL] [Abstract][Full Text] [Related]
28. Adherence therapy for people with schizophrenia. European multicentre randomised controlled trial.
Gray R; Leese M; Bindman J; Becker T; Burti L; David A; Gournay K; Kikkert M; Koeter M; Puschner B; Schene A; Thornicroft G; Tansella M
Br J Psychiatry; 2006 Dec; 189():508-14. PubMed ID: 17139034
[TBL] [Abstract][Full Text] [Related]
29. Early symptom response to antipsychotic medication as a marker of subsequent symptom change: an eighteen-month follow-up study of recent episode schizophrenia.
Levine SZ; Leucht S
Schizophr Res; 2012 Nov; 141(2-3):168-72. PubMed ID: 22995933
[TBL] [Abstract][Full Text] [Related]
30. Medication adherence and subjective weight perception in patients with first-episode psychotic disorder.
Wong MM; Chen EY; Lui SS; Tso S
Clin Schizophr Relat Psychoses; 2011 Oct; 5(3):135-41. PubMed ID: 21983497
[TBL] [Abstract][Full Text] [Related]
31. Effect of aripiprazole versus haloperidol on PANSS Prosocial items in early-episode patients with schizophrenia.
Docherty JP; Baker RA; Eudicone J; Mathew S; Marcus RN; McQuade RD; Mankoski R
Schizophr Res; 2010 Jul; 120(1-3):199-203. PubMed ID: 20547037
[TBL] [Abstract][Full Text] [Related]
32. Schizophrenia: Impact of psychopathology, faith healers and psycho-education on adherence to medications.
Abdel Aziz K; Elamin MH; El-Saadouni NM; El-Gabry DA; Barakat M; Alhayyas F; Moselhy HF
Int J Soc Psychiatry; 2016 Dec; 62(8):719-725. PubMed ID: 27815512
[TBL] [Abstract][Full Text] [Related]
33. Qualitative inquiry into motivators for maintaining medication adherence among Taiwanese with schizophrenia.
Chang YT; Tao SG; Lu CL
Int J Ment Health Nurs; 2013 Jun; 22(3):272-8. PubMed ID: 22882876
[TBL] [Abstract][Full Text] [Related]
34. Are we addressing the 'right stuff' to enhance adherence in schizophrenia? Understanding the role of insight and attitudes towards medication.
Beck EM; Cavelti M; Kvrgic S; Kleim B; Vauth R
Schizophr Res; 2011 Oct; 132(1):42-9. PubMed ID: 21820875
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for medication non-adherence in patients with first episode schizophrenia and related disorders; a prospective five year follow-up.
de Haan L; van Amelsvoort T; Dingemans P; Linszen D
Pharmacopsychiatry; 2007 Nov; 40(6):264-8. PubMed ID: 18030650
[TBL] [Abstract][Full Text] [Related]
36. Cognitive therapy for people with a schizophrenia spectrum diagnosis not taking antipsychotic medication: an exploratory trial.
Morrison AP; Hutton P; Wardle M; Spencer H; Barratt S; Brabban A; Callcott P; Christodoulides T; Dudley R; French P; Lumley V; Tai SJ; Turkington D
Psychol Med; 2012 May; 42(5):1049-56. PubMed ID: 21914252
[TBL] [Abstract][Full Text] [Related]
37. [Drug compliance and health locus of control in schizophrenia].
Combes C; Feral F
Encephale; 2011 May; 37 Suppl 1():S11-8. PubMed ID: 21600328
[TBL] [Abstract][Full Text] [Related]
38. A short message service (SMS)-based strategy for enhancing adherence to antipsychotic medication in schizophrenia.
Montes JM; Medina E; Gomez-Beneyto M; Maurino J
Psychiatry Res; 2012 Dec; 200(2-3):89-95. PubMed ID: 22901437
[TBL] [Abstract][Full Text] [Related]
39. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
[TBL] [Abstract][Full Text] [Related]
40. Symptom severity and attitudes toward medication: impacts on adherence in outpatients with schizophrenia.
Yang J; Ko YH; Paik JW; Lee MS; Han C; Joe SH; Jung IK; Jung HG; Kim SH
Schizophr Res; 2012 Feb; 134(2-3):226-31. PubMed ID: 22133906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]